CLPT EBITDA Growth
Clearpoint Neuro Inc · EBITDA Growth
CLPT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-34.14%period ending
CLPT TTM EBITDA YoY % (37.89% → -34.14%)
Year-over-year change
High-resolution chart · PNG
CLPT ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -34.138% | |
| -22.532% | |
| -28.8696% | |
| -26.5054% | |
| -24.5462% | |
| -0.2478% | |
| 17.5504% | |
| 21.1815% | |
| 18.6071% | |
| -10.4923% | |
| -33.4454% | |
| -37.4726% | |
| -32.8948% | |
| -19.8673% | |
| -21.3198% | |
| -50.1881% | |
| -95.5784% | |
| -150.5346% | |
| -166.1778% | |
| -97.7067% | |
| -62.636% | |
| -25.4088% | |
| -10.4685% | |
| -28.6012% | |
| -10.9229% | |
| 1.3093% | |
| 14.577% | |
| 33.7615% | |
| 28.9776% | |
| 24.7042% | |
| 17.8752% | |
| -2.6641% | |
| 13.2448% | |
| 7.2026% | |
| 11.9491% | |
| 16.6141% | |
| -4.8688% | |
| 15.0837% | |
| 13.1078% | |
| 25.6815% | |
| 34.0628% | |
| 16.8971% | |
| 13.3167% | |
| -7.3932% | |
| -25.8385% | |
| -18.9228% | |
| -31.6788% | |
| -59.5505% | |
| -71.1291% | |
| -166.5769% | |
| -157.0631% | |
| -48.5408% | |
| -25.8407% | |
| 37.8868% |